What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
Gordon W. Dewald focuses on Internal medicine, Immunology, Cytogenetics, Pathology and Leukemia.
His research in Internal medicine intersects with topics in Gastroenterology, Surgery and Oncology.
His work in Immunology addresses subjects such as Cancer research, which are connected to disciplines such as ABL, Gene rearrangement and Polycythemia vera.
Gordon W. Dewald has researched Cytogenetics in several fields, including Karyotype and Chromosomal translocation.
Gordon W. Dewald combines subjects such as Stem cell marker, Trisomy, Immunophenotyping, Lymphocyte and Histamine with his study of Pathology.
Gordon W. Dewald works mostly in the field of Leukemia, limiting it down to topics relating to Multivariate analysis and, in certain cases, Myelogenous and Cancer, as a part of the same area of interest.
His most cited work include:
- Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion (1019 citations)
- Establishment of an immature mast cell line from a patient with mast cell leukemia. (660 citations)
- Anthracycline Dose Intensification in Acute Myeloid Leukemia (636 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Pathology, Cytogenetics, Immunology and Chromosome.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Surgery and Oncology.
His Pathology study combines topics from a wide range of disciplines, such as Fluorescence in situ hybridization and Chromosome abnormality.
His Cytogenetics research is multidisciplinary, incorporating elements of Clone, Monosomy, Karyotype and Chromosomal translocation.
His research investigates the connection between Immunology and topics such as Cancer research that intersect with problems in ABL.
Gordon W. Dewald has researched Myelodysplastic syndromes in several fields, including Hematology and Myeloproliferative Disorders.
He most often published in these fields:
- Internal medicine (36.20%)
- Pathology (33.74%)
- Cytogenetics (30.06%)
What were the highlights of his more recent work (between 2007-2021)?
- Internal medicine (36.20%)
- Oncology (15.34%)
- Pathology (33.74%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Oncology, Pathology, Immunology and Surgery.
His Internal medicine study frequently draws connections between adjacent fields such as Gastroenterology.
His Oncology research integrates issues from T cell and False Negative Reactions.
His work deals with themes such as Cancer, Karyotype, Monoclonal gammopathy, Cytogenetics and Fluorescence in situ hybridization, which intersect with Pathology.
His Immunology research is multidisciplinary, relying on both Molecular biology and Disease.
In his study, Myeloproliferative Disorders, Neutropenia, Lenalidomide and Cancer research is strongly linked to Myelodysplastic syndromes, which falls under the umbrella field of Hematology.
Between 2007 and 2021, his most popular works were:
- Anthracycline Dose Intensification in Acute Myeloid Leukemia (636 citations)
- Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1–risk myelodysplastic syndromes with karyotypes other than deletion 5q (373 citations)
- T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). (232 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Internal medicine, Surgery, Pathology, Chronic lymphocytic leukemia and Transplantation are his primary areas of study.
Gordon W. Dewald has included themes like Gastroenterology and Oncology in his Internal medicine study.
His Surgery study which covers Myeloid leukemia that intersects with Myelodysplastic syndromes, Haploinsufficiency and Lenalidomide.
His Pathology research includes themes of Fluorescence in situ hybridization and Trisomy 8, Cytogenetics.
His Chronic lymphocytic leukemia research incorporates elements of Stromal cell, Bone marrow, Cohort and CD38.
His Hematology study is concerned with the field of Immunology as a whole.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
